Infectious disease Archives

News and Trends 16 Jun 2016

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Allecra Therapeutics has raised €22M in its Series B round from some key investors. The money will back the Phase II trials for a new broad-spectrum antibiotic for resistant bacteria. The development of antibiotic resistance in bacteria has been one of the key concerns of healthcare authorities for quite some time. The World Health Organisation estimates […]

June 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Jun 2016

Immunotherapy reaches Breakthrough in eliminating HIV

Immunocore has published key results for its new preclinical candidate for HIV, ImmTAV. This TCR-based immunotherapy has succeeded in targeting T-cells where HIV infection often ‘hides’ from drugs. Just after presenting promising results from its leading candidate at ASCO 2016 (read our coverage here), Immunocore is making headlines in another area – infectious disease. The […]

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Jun 2016

Gates Foundation is funding EU Biotech to make Vaccines more affordable

Batavia Biosciences has won a €3.3M grant from the Gates Foundation, to fund new research in making cell culture cheaper – and drive down the price of some key vaccines. Within its goal of pushing science forward and bringing to developing countries, the Gates Foundation has outlined vaccine delivery as a key part of its strategy. […]

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Jun 2016

Genticel is vaccinating against Cervical Cancer AFTER Infection

Estonia, our previous destination by the Baltic Sea, was a delightful and a full of potential place to visit. This week, we are heading down to the relaxing and sunny south of France, more precisely to Toulouse, once the capital of the Visigothic Kingdom and current to the Midi-Pyrénées region, the largest region in metropolitan France. It […]

June 10, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 24 May 2016

Danish ‘safer’ vaccine for Smallpox gets US order worth €90M

Bavarian Nordic will receive €90M from the US’ BARDA for its nonreplicating smallpox vaccine – which can be administered to people with conditions like HIV. Bavarian Nordic is one of the Copenhagen-based Biotechs you need to know which is developing cancer immunotherapies and vaccines against infectious diseases. Its infectious disease programme is based on their vaccine technology which uses an […]

May 24, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 23 May 2016

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

Researchers from University of Cambridge and the Wellcome Trust Sanger Institute have discovered that Ebola can still be transmitted through sex and breastfeeding after quarantine – causing ‘flare-ups’ even though the epidemic has ended. Without effective vaccines or treatments for Ebola infection, the 2014’s outbreak in West Africa was contained due to public health measures. These […]

May 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 18 May 2016

Polish Bioinformatics company backs US movement into Microbiome Research

In Kraków, the Bioinformatics company Ardigen has now partnered up with a US based Microbiome startup, EpiBiome, which is looking for the answer to antibiotic resistance. This is another example of cross-Atlantic collaboration in the Microbiome world, just as President Obama pledges €105M ($121M) to the up and coming field of therapeutics. It’s a growing area of research, and as […]

May 18, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 9 May 2016

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of its herpes cure pritelivir. Update (17/01/2017): The company has presented results from its first Phase II trial with pritelivir. The drug candidate proved to work better than the antiviral drug valacyclovir, currently the standard of care. Update (01/12/2017): AiCuris announced […]

May 9, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 7 May 2016

BioArt: Vibrant Paper Vaccines, Vitamins and Controversial Farming

Zim & Zou are a French duo making colourful 3D models. Their vibrant art raises awareness of the food industry, healthy eating and children’s vaccination. Zim & Zou is the graphic design studio of Thibaut Zimmerman and Lucie Thomas, based in Nancy (France). After studying design, the two 28-year olds moved away from digital work to focus on tangible installations […]

May 7, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 3 May 2016

Handheld Genetic Test proves itself for Hep-C with 100% Accuracy

Epistem’s molecular diagnostic (Genedrive) has achieved 100% accuracy in detecting a genotype relevant to Hepatitis – an important proof of concept for this field device. Located in Manchester (UK), Epistem has a market cap of €130,000 and 29 employees. One of its research areas is molecular diagnostics, under which it developed Genedrive. This device can make […]

May 3, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 3 May 2016

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants infected with a life-threatening virus – respiratory syncytial virus (RSV). Located near Ghent (Belgium), Ablynx is making advances in its Nanobody platform, based on the shorter monoclonal antibodies of llamas. Due to their small size, these Nanobodies can be used in a […]

May 3, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 27 Apr 2016

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

This is my first interview from BioTrinity 2016 in London. I met with Tom Johnston, CEO of Mucosis, to learn more about the needle-free vaccine platform he is developing. Mucosis is a biotechnology company based in Gröningen, Netherlands (a city we covered here for its medtech innovation). It was founded in 2007 and has raised over €20M so […]

April 27, 2016 - 1 minutemin - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Infectious disease

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Immunotherapy reaches Breakthrough in eliminating HIV

Gates Foundation is funding EU Biotech to make Vaccines more affordable

Genticel is vaccinating against Cervical Cancer AFTER Infection

Danish ‘safer’ vaccine for Smallpox gets US order worth €90M

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

Polish Bioinformatics company backs US movement into Microbiome Research

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

BioArt: Vibrant Paper Vaccines, Vitamins and Controversial Farming

Handheld Genetic Test proves itself for Hep-C with 100% Accuracy

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!